Insmed Inc (INSM)

HEALTH CARE: PHARMACEUTICALS
SIC: PHARMACEUTICAL PREPARATIONS

10 FINDERNE AVENUE BRIDGEWATER, NJ 08807

Discovers and develops drug candidates for the treatment of metabolic diseases and endocrine disorders. The company's lead product candidates include recombinant human (rh) IGF-I/rhIGFBP-3, for the treatment of growth hormone insensitivity syndrome.

Data based on most recent fiscal year report
Market Cap1.567 Billion Shares Outstanding76.61 Million Avg Volume1.148 Million
1-Yr BETA vs S&P TR Current Ratio8.72 Quick Ratio8.72
View SEC Filings from INSM instead.
Q2 2019 All Institutions Hedge Funds 1
To trade INSM now:
Filers who had this stock in their top 10: 6 4 (0.41%)
13F Filers holding this stock: 168 36 (3.72%)
Aggregate 13F shares on 06/30/2019: 125.399 Million 23.618 Million
Aggregate 13F shares on 03/31/2019: 81.411 Million 15.861 Million
Percent change: 54.03% 48.90%
Funds creating new positions: 34 11
Funds Adding to an existing position: 81 19
Funds closing out their position: 20 5
Funds reducing their position: 34 4
1 hedge funds as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding INSM (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

KOLLENDER RICHARD S CHIEF OPERATING OFFICER

  • Officer
100,000 2019-09-03 0

POTTER MYRTLE S

  • Director
0 2019-08-23 0

TOMBESI PAOLO CHIEF FINANCIAL OFFICER

  • Officer
0 2019-08-19 1

ANDERSON ELIZABETH M

  • Director
4,490 2019-07-09 3

GLOVER STEVE C

  • Director
0 2019-06-28 0

LEWIS WILLIAM CHAIRMAN, PRESIDENT & CEO

  • Officer
  • Director
80,672 2019-06-25 5

MCGIRR DAVID W J

  • Director
0 2019-06-25 1

DRECHSLER ANDREW T CHIEF FINANCIAL OFFICER

  • Officer
0 2019-06-24 0

WHITCOMB RANDALL W

  • Director
0 2019-06-20 0

ALTOMARI ALFRED CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
258,568 2019-06-10 5

SCHAEFFER ORLOV S NICOLE CHIEF PEOPLE STRATEGY OFFICER

  • Officer
24,350 2019-06-06 3

GOLL JOHN CHIEF ACT. OFF. & CONTROLLER

  • Officer
7,322 2019-06-03 1

HAYDEN DONALD J JR

0 2019-05-31 2

LANFEAR DENNIS M PRESIDENT & CEO

  • Officer
  • Director
1,496,166 2019-05-30 0

SHAROKY MELVIN MD

  • Director
258,693 2019-05-15 2

ENGELSEN STEINAR J

  • Director
288,202 2019-05-15 2

PELLIZZARI CHRISTINE A CHIEF LEGAL OFFICER

  • Officer
67,554 2019-05-15 2

BRENNAN DAVID R

  • Director
55,221 2019-05-15 1

ADSETT ROGER CHIEF COMMERCIAL OFFICER

  • Officer
41,168 2019-05-15 3

LEE LEO

  • Director
12,965 2019-05-15 1

SORIANO JOHN CHIEF COMPLIANCE OFFICER

  • Officer
13,892 2019-05-15 2

PAULS MATTHEW

  • Director
20,000 2019-04-23 0

FMR LLC

  • SEE REMARK 1
3,738,248 2019-04-01 0

STRECK PAUL CHIEF MEDICAL OFFICER

  • Officer
0 2019-01-21 0

GUPTA RENU

  • Director
0 2017-05-25 0

SULLIVAN EUGENE JEFFREY CHIEF MED. & SCIENTIFIC OFC.

  • Officer
0 2017-05-17 0

QUIGLEY MARK VICE PRESIDENT, QUALITY

  • Officer
0 2015-05-12 0

BERRY PEGGY VICE PRESIDENT, REGULATORY

  • Officer
0 2015-02-26 0

AYER CAPITAL MANAGEMENT, LP

AYER CAPITAL PARTNERS, LLC

ACM CAPITAL PARTNERS, LLC

VENKATESAN JAY

  • Director
  • 10% Owner
5,604,015 2013-12-31 0

DRUCKER ANDREA HOLTZMAN SVP, GEN. COUNSEL & CORP SEC.

  • Officer
45,000 2013-06-03 0

WHITTEN TIMOTHY PRESIDENT & CEO

  • Officer
  • Director
10,000 2012-06-01 0

TULLY KEVIN P EXECUTIVE VP & CFO

  • Officer
0 2011-12-21 0

LABELLA NICHOLAS A. JR. CHIEF SCIENTIFIC OFFICER

  • Officer
0 2011-12-21 0

GURRERI NICHOLAS LEE SENIOR VP, COMMERCIAL OPS

  • Officer
0 2011-01-31 0

CONDON KENNETH G

  • Director
168,504 2010-06-09 0

CROOKE GRAHAM K

  • Director
228,404 2010-06-09 0

FARRAR DOUG VICE PRESIDENT, ITP

  • Officer
292,055 2009-03-31 0

ALLAN GEOFFREY PRESIDENT, CEO AND CHAIRMAN

  • Officer
  • Director
1,715,557 2009-03-31 0

KELLEY GLEN L VP, REGULATORY AFFAIRS

  • Officer
213,712 2009-03-31 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5
No current insider transactions
Click here to report any possible errors with this stock listing.

Elevate your investments